TSTorsten Sommer

Torsten Sommer

*This is an algorithmically generated author record based on publicly available information.

Torsten Sommer has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • H. Schild

    3 shared publications
  • Hans Schild

    From the Departments of Radiology (T.S., C.P.N., M.H., A.S., C.M., K.S., H.S.) and Cardiology (A.Y., D.S.), University of Bonn, Bonn, Germany; Medtronic Bakken Research Center (V.Z.), Maastricht, Netherlands; Department of Cardiology and Angiology (C.V.), Hospital of the University of Muenster, Muenster, Germany; and Department of Radiology of the University of Pennsylvania School of Medicine (H.L.), Philadelphia, Pa

    3 shared publications
  • U. Hofer

    3 shared publications
  • A. Schmiedel

    2 shared publications
  • Alexandra Schmiedel

    From the Departments of Radiology (T.S., C.P.N., M.H., A.S., C.M., K.S., H.S.) and Cardiology (A.Y., D.S.), University of Bonn, Bonn, Germany; Medtronic Bakken Research Center (V.Z.), Maastricht, Netherlands; Department of Cardiology and Angiology (C.V.), Hospital of the University of Muenster, Muenster, Germany; and Department of Radiology of the University of Pennsylvania School of Medicine (H.L.), Philadelphia, Pa

    2 shared publications
  • Christian Vahlhaus

    From the Departments of Radiology (T.S., C.P.N., M.H., A.S., C.M., K.S., H.S.) and Cardiology (A.Y., D.S.), University of Bonn, Bonn, Germany; Medtronic Bakken Research Center (V.Z.), Maastricht, Netherlands; Department of Cardiology and Angiology (C.V.), Hospital of the University of Muenster, Muenster, Germany; and Department of Radiology of the University of Pennsylvania School of Medicine (H.L.), Philadelphia, Pa

    2 shared publications

Latest Publications

  • Top Cited Papers

    Strategy for Safe Performance of Extrathoracic Magnetic Resonance Imaging at 1.5 Tesla in the Presence of Cardiac Pacemakers in Non–Pacemaker-Dependent Patients

    by Torsten Sommer, Claas P. Naehle, Alexander Yang, Volkert Zeijlemaker, Matthias Hackenbroch, Alexandra Schmiedel, Carsten Meyer, Katharina Strach, Dirk Skowasch, Christian Vahlhaus, et al.

    Background— The purpose of the present study was to evaluate a strategy for safe performance of extrathoracic magnetic resonance imaging (MRI) in non–pacemaker-dependent patients with cardiac pacemakers. Methods and Results— Inclusion criteria were presence of a cardiac pacemaker and urgent clinical need for an MRI examination. Pacemaker-dependent patients and those requiring examinations of the thoracic region were excluded. The study group consisted of 82 pacemaker patients who underwent a total of 115 MRI examinations at 1.5T. To minimize radiofrequency-related lead heating, the specific absorption rate was limited to 1.5 W/kg. All pacemakers were reprogrammed before MRI: If heart rate was 60 bpm, sense-only mode was used to avoid MR-induced competitive pacing and potential proarrhythmia. Patients were monitored with ECG and pulse oximetry. All pacemakers were interrogated immediately before and after the MRI examination and after 3 months, including measurement of pacing capture threshold (PCT) and serum troponin I levels. All MR examinations were completed safely. Inhibition of pacemaker output or induction of arrhythmias was not observed. PCT increased significantly from pre- to post-MRI ( P =0.017). In 2 of 195 leads, an increase in PCT was only detected at follow-up. In 4 of 114 examinations, troponin increased from a normal baseline value to above normal after MRI, and in 1 case (troponin pre-MRI 0.02 ng/mL, post-MRI 0.16 ng/mL), this increase was associated with a significant increase in PCT. Conclusions— Extrathoracic MRI of non–pacemaker-dependent patients can be performed with an acceptable risk-benefit ratio under controlled conditions and by taking both MR- and pacemaker-related precautions.


  • Coronary MR Angiography at 3.0 T versus That at 1.5 T: Initial Results in Patients Suspected of Having Coronary Artery Disease

    by Torsten Sommer, Matthias Hackenbroch, Ulrich Hofer, Alexandra Schmiedel, Winfried A. Willinek, Sebastian Flacke, Jürgen Gieseke, Frank Träber, Rolf Fimmers, Harold Litt, et al.

    To prospectively evaluate the feasibility, image quality, and accuracy of coronary magnetic resonance (MR) angiography at 3.0 T in patients suspected of having coronary artery disease and to prospectively compare these results with those of coronary MR angiography performed at 1.5 T. The study was approved by the institutional review board, and informed consent was obtained from all patients. Eighteen patients (11 men, seven women; mean age, 63 years; age range, 45-76 years) suspected of having coronary artery disease who were scheduled to undergo elective conventional coronary angiography (reference standard) were included. For coronary MR angiography at 3.0 and 1.5 T, a vector electrocardiographically gated three-dimensional segmented k-space gradient-echo imaging sequence was combined with real-time respiratory navigator gating and tracking. Signal-to-noise ratios (SNRs), contrast-to-noise ratios (CNRs), scores of image quality and sensitivity and specificity for the detection of coronary artery stenosis on a segment-by-segment basis were assessed at 3.0 and 1.5 T. Data were analyzed for statistical differences by using the Wilcoxon matched-pairs test and the McNemar test. The average increase in SNR at 3.0 T with respect to that at 1.5 T was 29.5% for the left coronary artery (LCA) and 31.2% for the right coronary artery (RCA) (P < .001), and the average increase in CNR was 21.8% for the LCA and 23.5% for the RCA (P < .001). Scores of image quality (P = .77) and diagnostic accuracy for the detection of coronary artery stenoses (sensitivity and specificity: 82% and 89%, respectively, at 3.0 T vs 82% and 88% at 1.5 T; P > .99) were identical or almost identical at both field strengths. Coronary MR angiography at 3.0 T is feasible in patients suspected of having coronary artery disease and yields significant increases in SNR and CNR, although current techniques do not result in significantly improved image quality and diagnostic accuracy compared with the quality and accuracy at 1.5 T. (c) RSNA, 2005.


  • Hochfeld-Magnetresonanztomographie: Magnetische Anziehungs- und Rotationskräfte auf metallische Implantate bei 3,0 T

    by T. Sommer, D. Maintz, A. Schmiedel, M. Hackenbroch, U. Hofer, H. Urbach, C. Pavlidis, F. Träber, H. Schild, M. Höher

    Ziel: Die In-vitro-Evaluierung verschiedener biomedizinischer Implantate hinsichtlich der auf sie wirkenden magnetischen Anziehungs- und Rotationskräfte an einem 3,0-Tesla-MRT-System. Methode: Es wurden 53 metallische Implantate (14 intrakranielle Aneurysmaclips, 19 Koronararterien- sowie 20 Iliakalarterienstents) an einem 3,0-Tesla-MRT-System (Gyroscan Intera 3.0 T, Philips) untersucht. Die Bestimmung der auf die Implantate im statischen Magnetfeld wirkenden Translationskräfte Fz erfolgte mithilfe des Fadentests über die Messung der Deflektionswinkels β. Die Evaluierung der Rotationskraft Frot erfolgte qualitativ mit einer 5-Punkte-Graduierung (Grad 0: keine Rotationskraft, Grad 4: starke Rotationskraft). Ergebnisse: Bei 52 von 53 getesteten Implantaten blieb die Translationskraft Fz unterhalb der auf das jeweilige Implantat wirkenden Gravitationskraft (β: 0 - 21°, Fz: 0 - 3,8 mN). Bei keinem dieser 52 Implantate wurde eine Rotation relativ zum Magnetfeld B0 (Rotationskraft Grad 0/4) beobachtet. Bei einem Implantat, einem Iliakalarterienstent aus Edelstahl (Zenith, Fa. Cook), wurde ein Deflektionswinkel β von 88° gemessen, entsprechend einer Translationskraft Fz von 299 mN, die dem 29fachen der auf das Implantat wirkenden Gravitationskraft entspricht. Hierzu konkordant zeigten sich in der qualitativen Evaluierung deutliche auf diesen Stent wirkende Rotationskräfte Grad 4/4. Schlussfolgerungen: 52 von 53 getesteten Implantaten können bezüglich der auf sie wirkenden magnetischen Anziehungs- und Rotationskräfte nach ASTM-Kriterien als „sicher” bei der Verwendung in einem MRT-System mit der Feldstärke 3,0 Tesla klassifiziert werden. Purpose: To evaluate magnetic field interactions of commonly used biomedical implants at 3.0 Tesla. Materials and Methods: Fourteen aneurysm clips designed for permanent placement in intracranial aneurysms, 19 coronary artery stents and 20 iliac artery stents were evaluated in an actively shielded compact 3.0 T MR system (Intera, Philips Medical Systems, Best, The Netherlands, length of magnet 1.57 m). The magnetic deflection forces (translational movement) were evaluated as follows: The implants were suspended by a fine string and placed in the magnet bore at the location of the maximum magnetic field gradient. The translational forces Fz were calculated from the measured angle of deflection from the vertical axis. The magnetic field-induced torque (rotational forces) was evaluated as follows: Each implant was placed in the center of the magnetic bore parallel to the static magnetic field B0 (position 0°). Any possible displacement of the implant was noted on a millimeter scale and any torque qualitatively evaluated using a 5 point grading scale (0: no torque; + 4: very strong torque). The implant was turned in steps of 45°, and the procedure was repeated to encompass a full 360° rotation. Results: In 52 of the 53 devices tested, the deflection force (deflection angle: range 0-21°, translational force: range 0-3.8 mN) was less than the gravitational force (i.e., the implant’s weight). These devices (n = 52/53) did not show any alignment to or rotation in the magnetic field at any of the various 45°-increment positions corresponding to a qualitative torque evaluation of grade 0/4. One device (n = 1/53), an iliac artery stent made of stainless steel (Zenith, Cook, Mönchengladbach, BRD), was found to have deflection forces (deflection angle 88° translational force 299 mN) greatly exceeding the gravitational force as well as a pronounced torque (grade 4/4). Conclusion: Out of 53 biomedical implants evaluated for magnetic field interactions at 3.0 T, one iliac artery stent made of stainless steel was found to be potentially unsafe based on ASTM criteria. MR imaging at 3.0 Tesla may be performed safely in patients with any of the other 52 different implants evaluated in this study with respect to magnetic field translational attraction and torque. 10 Ergebnisse dieser Arbeit sind Teil der Dissertationsschrift von Frau cand. med. Bettina Schmiedel.


  • Stress-Cine-MRT zur Primärdiagnostik der koronaren Herzkrankheit

    by T. Sommer, U. Hofer, H. Omran, H. Schild

    Belastungsuntersuchungen sind einer der wesentlichen Pfeiler der nicht-invasiven Diagnostik der koronaren Herzkrankheit (KHK). Die Stress-Cine-Magnetresonanztomographie (Stress-MRT) beruht wie die Stressechokardiographie auf dem direkten Nachweis ischämieinduzierter Wandbewegungsstörungen. Ihr Einsatz bei kardialen Belastungsuntersuchungen wurde bisher vor allem durch die langen Untersuchungszeiten und die limitierten Überwachungsmöglichkeiten der Patienten eingeschränkt. Erst seit kurzem wurden durch technische Weiterentwicklungen (insbesondere ultraschnelle k-Raum-segmentierte Sequenzen) die wesentlichen Rahmenbedingungen für eine klinisch praktikable kardiale MRT-Belastungsdiagnostik geschaffen. Als Stress-Induktoren können physikalische (Fahrradergometrie) und pharmakologische Belastungsverfahren (β1-Mimetika [Dobutamin] oder Vasodilatatoren [Dipyridamol, Adenosin]) eingesetzt werden. Insbesondere seit der Etablierung von Hochdosis-Protokollen mit fakultativer Atropingabe wird die Belastung mit Dobutamin bei der Stress-MRT zum Nachweis einer KHK (Sensitivität: 83 - 87 %; Spezifität: 83 - 86 %) von den meisten Arbeitsgruppen favorisiert. Schwerere Komplikationen treten in 0,25 % der Fälle auf. Im direkten Vergleich zeigte sich die Dobutamin-Stress-MRT aufgrund der besseren Bildqualität der Dobutamin-Stressechokardiographie überlegen (Sensitivität: 86,2 % vs. 74,3 %, p < 0,05; Spezifität: 85,7 % vs. 69,8 %, p < 0,05). Die Stress-MRT ist bereits zum jetzigen Zeitpunkt eine realistische - in der Routinediagnostik anwendbare - Alternative zur Stressechokardiographie. Vom Einsatz der Stress-MRT profitieren zur Zeit v. a. Patienten, bei denen aufgrund grundsätzlich schlechter Schallbarkeit mit hoher Wahrscheinlichkeit von nicht oder nur eingeschränkt beurteilbaren stressechokardiographischen Untersuchungen auszugehen ist. Stress testing is the cornerstone in the diagnosis of patients with suspected coronary artery disease (CAD). Stress echocardiography has become a well-established modality for the detection of ischemia-induced wall motion abnormalities. However, display and reliable interpretation of stress echocardiography studies are user-dependent, the test reproducibility is low, and 10 to 15 % of patients yield suboptimal or non-diagnostic images. Due to its high spatial and contrast resolution, MRI is known to permit an accurate determination of left ventricular function and wall thickness at rest. Early stress MRI studies provided promising results with respect to the detection of CAD. However, the clinical impact was limited due to long imaging time and problematic patient monitoring in the MRI environment. Recent technical improvements - namely ultrafast MR image acquisition - led to a significant reduction of imaging time and improved patient safety. Stress can be induced by physical exercise or pharmacologically by administration of a beta1-agonist (dobutamine) or vasodilatator (dipyridamole and adenosine). The best developed and most promising stress MRI technique is a high-dose dobutamine/atropine stress protocol (10, 20, 30, 40 μg/kg/min; optionally 0.25-mg fractions of atropine up to maximal dose 1 mg). Severe complications (myocardial infarction, ventricular fibrillation and sustained tachycardia, cardiogenic shock) may be expected in 0.25 % of patients. Currently, data of three high-dose dobutamine stress MRI studies are available, revealing a good sensitivity (83 - 87 %) and specificity (83 - 86 %) in the assessment of CAD. The direct comparison between echocardiography and MRI for the detection of stress-induced wall motion abnormalities yielded better results for dobutamine-MRI in terms of sensitivity (86.2 % vs. 74.3 %; p < 0.05) and specificity (85.7 % vs. 69.8 % p < 0.05) as compared to dobutamine stress echocardiography. The superior results of MRI can mainly be explained by the better image quality with sharp delineation of the endocardial and epicardial borders. Currently, stress MRI is already a realistic clinical alternative for the non-invasive assessment of CAD in patients with impaired image quality in echocardiography.


  • Hochauflösende 3D-MR-Koronarangiographie inEcht-Zeit-Navigatortechnik: Ergebnisse aus107 Patientenuntersuchungen

    by T. Sommer, U. Hofer, M. Hackenbroch, C. Meyer, S. Flacke, A. Schmiedel, C. Schmitz, K. Thiemann, H. Omran, H. Schild

    Zielsetzung: Beurteilung der diagnostischen Zuverlässigkeit der hochauflösenden 3D-MR-Koronarangiographie in Echt-Zeit-Navigator-Technik an einem großen Patientenkollektiv mit Verdacht auf koronare Herzerkrankung (KHK). Methode: 107 Patienten mit Verdacht auf KHK wurden prospektiv mit einer EKG-getriggerten fettunterdrückten GE-Sequenz (Auflösung in plane 0,70 × 0,79 mm2) bei freier Atmung mit Echt-Zeit-Gating der Zwerchfellbewegung an einem 1,5 T-System (Philips, Intera) untersucht. Bei allen Patienten wurde eine konventionelle Koronarangiographie durchgeführt. Bei der Auswertung der MRT-Bilder erfolgte eine qualitative Beurteilung der Bildqualität (1: scharfe Begrenzung der Koronararterien (KA), 2: geringe Unschärfe der KA, 3: deutliche Unschärfe der KA, 4: KA nicht oder kaum abgrenzbar). Ergebnisse: Eine Bildqualität Grad 1 wurde in 24 %, Grad 2 in 48 %, Grad 3 in 24 % und Grad 4 in 4 % der Patienten erzielt. In den MR-Koronarangiographien mit diagnostischer Bildqualität (Grad 1 und 2, n = 77/107 (72 %) betrugen die Sensitivität und Spezifität im Nachweis von Koronarstenosen > 50 %, in den proximalen und mittleren Abschnitten der Hauptäste der KA 88 % bzw. 91 %. Schlussfolgerungen: 1) Die hochauflösende 3D-MR-Koronarangiographie in Echt-Zeit-Navigatortechnik ermöglicht bei selektionierten Patienten eine sehr gute Beurteilung der proximalen und mittleren Abschnitte der Koronararterienhauptäste. 2) Eine diagnostisch verwertbare Bildqualität kann allerdings nur bei 72 % der Patienten erreicht werden. Purpose: To evaluate the clinical value of high-resolution coronary MR angiography (coronary MRA) in a large group of patients with suspected coronary artery disease. Methods and Material: 107 patients with suspected coronary artery disease underwent free-breathing coronary MRA (Intera, 1.5 T, Philips Medical Systems). To compensate for artefacts due to respiratory motion, a right hemidiaphragmatic navigator with real time-time slice correction was used. An ECG-gated, fat-suppressed, 3D segmented-k-space gradient echo sequence (in plane resolution 0.70 × 0.79 mm2) was used. Cardiac catheterization with selective coronary angiography was performed in all patients. Visualization of the coronary arteries (CA) was qualitatively assessed using a four-point grading scale. Results: Image quality of grade 1 was achieved in 24 %, grade 2 in 48 %, grade 3 in 24 % and grade in in 4 % of patients. Based on an evaluation of the coronary MRAs of all patients (n = 107) sensitivity and specificity for the detection of stenoses > 60 % in the proximal and middle main coronary arteries were 74 % and 63 %, respectively. In coronary MRAs with good quality [grade 1 and 2, n = 77/107 (72 %)] sensitivity and specificity for the detection of coronary stenoses were 88 % and 91 %, respectively. Conclusion: Submillimeter 3D coronary MRA with real-time navigator correction allows high quality imaging of the proximal and middle main coronary arteries with good sensitivity and specificity for detection of stenoses > 50 % in selected patients. However, in abaout 28 % of patients image quality is severely impaired.


  • MR Imaging and Cardiac Pacemakers: In Vitro Evaluation and in Vivo Studies in 51 Patients at 0.5 T

    by Torsten Sommer, Christian Vahlhaus, Gerhard Lauck, Alexander V. Smekal, Marcus Reinke, Ulrich Hofer, Wolfgang Block, Frank Träber, Christian Schneider, Jürgen Gieseke, et al.

    PURPOSE: To evaluate the safety and feasibility of magnetic resonance (MR) imaging at 0.5 T in patients with implanted cardiac pacemakers. MATERIALS AND METHODS: Twenty-one models of pacemakers and 44 pacemaker electrodes were exposed to in vitro MR imaging with continuous registration of pacemaker output and temperature at the lead tip. Prior to MR imaging examination, pacemakers were programmed to an asynchronous mode (A00, V00, or D00). Pacemakers were examined before and after MR imaging. Forty-four patients with implanted pacemakers underwent 51 MR imaging examinations under cardiologic surveillance, continuous electrocardiography, pulse oximetry, and capnographic monitoring. RESULTS: MR imaging was safely performed in all patients. None of the pacemakers displayed a pacing dysfunction at MR imaging. No changes occurred in the programmed parameters in any device tested in vivo or in vitro. Maximum increases in the temperature at the lead tips were 8.90°C at a specific absorption rate (SAR) of 0.6 W/k...